Table 1.
Subject Demographics and Characteristics
| Placebo (N = 8) | 2‐mg Baricitinib (N = 8) | 4‐mg Baricitinib (N = 9) | 10 mg Baricitinib (N = 8) | Overall (N = 33) | |
|---|---|---|---|---|---|
| Age, y | 26.6 (5.4) | 30.8 (7.3) | 26.6 (3.5) | 27.6 (6.7) | 27.8 (5.8) |
| Male, n (%) | 8 (100.0) | 8 (100.0) | 9 (100.0) | 8 (100.0) | 33 (100.0) |
| Weight, kg | 65.23 (8.05) | 63.44 (6.23) | 63.78 (5.44) | 61.94 (1.93) | 63.60 (5.68) |
| BMI, kg/m2 | 22.34 (1.21) | 22.15 (1.75) | 21.87 (1.28) | 21.68 (1.39) | 22.01 (1.38) |
BMI, body mass index; N, number of subjects; SD, standard deviation.
Values shown are for mean (SD) unless otherwise noted.